Idexx Laboratories
(IDXX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 1,031,633 | 1,024,030 | 922,555 | 739,117 | 638,095 |
| Cost of Goods | 505,352 | 494,264 | 459,033 | 359,588 | 315,195 |
| Gross Profit | 526,281 | 529,766 | 463,522 | 379,529 | 322,900 |
| Operating Expenses | 350,664 | 357,574 | 327,372 | 252,184 | 207,764 |
| Operating Income | 175,969 | 172,456 | 136,183 | 127,933 | 115,331 |
| Interest Expense | 1,916 | 4,589 | 4,179 | 462 | 96 |
| Other Income | 486 | 2,320 | 2,839 | 3,279 | 3,237 |
| Pre-tax Income | 174,539 | 170,187 | 134,843 | 130,750 | 118,472 |
| Income Tax | 52,304 | 54,018 | 40,829 | 37,224 | 40,670 |
| Net Income Continuous | 122,235 | 116,169 | 94,014 | 93,678 | 78,254 |
| Minority Interests | 10 | 0 | N/A | N/A | N/A |
| Net Income | $122,225 | $116,169 | $94,014 | $93,678 | $78,254 |
| EPS Basic Total Ops | 1.04 | 0.97 | 0.77 | 0.75 | 0.60 |
| EPS Basic Continuous Ops | 1.04 | 0.97 | 0.76 | 0.75 | 0.60 |
| EPS Diluted Total Ops | 1.01 | 0.94 | 0.73 | 0.71 | 0.58 |
| EPS Diluted Continuous Ops | 1.01 | 0.93 | 0.73 | 0.71 | 0.57 |
| EBITDA(a) | $225,742 | $220,440 | $177,141 | $157,749 | $139,700 |